InvestorRoom | Kitov Pharmaceuticals http://kitovpharma.investorroom.com/ U.S. Food and Drug Administration Grants Kitov a Waiver for New Drug Application Filing Fee http://kitovpharma.investorroom.com/news-releases?item=46 Mon, 03 Apr 2017 02:25:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=46 TyrNovo, a Kitov company, to Present Preclinical Data at the American Association for Cancer Research Annual Meeting http://kitovpharma.investorroom.com/news-releases?item=45 Mon, 27 Mar 2017 08:58:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=45 Kitov Announces License Agreement for KIT-302 in South Korea http://kitovpharma.investorroom.com/news-releases?item=44 Wed, 08 Mar 2017 09:03:00 -0500 http://kitovpharma.investorroom.com/news-releases?item=44 Kitov Provides Further Update on Formal Investigation by Israeli Securities Authority http://kitovpharma.investorroom.com/2017-02-09-Kitov-Provides-Further-Update-on-Formal-Investigation-by-Israeli-Securities-Authority Thu, 09 Feb 2017 10:52:00 -0500 http://kitovpharma.investorroom.com/2017-02-09-Kitov-Provides-Further-Update-on-Formal-Investigation-by-Israeli-Securities-Authority Kitov Announces Initiation of Formal Investigation by Israeli Securities Authority http://kitovpharma.investorroom.com/2017-02-07-Kitov-Announces-Initiation-of-Formal-Investigation-by-Israeli-Securities-Authority Tue, 07 Feb 2017 10:37:00 -0500 http://kitovpharma.investorroom.com/2017-02-07-Kitov-Announces-Initiation-of-Formal-Investigation-by-Israeli-Securities-Authority